PDCD1 and colorectal cancer: Specifically, programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1) inhibitors (e.g., toripalimab) are recommended for patients with advanced or metastatic dMMR colorectal cancer (2).